Like human CF disease, P. aeruginosa infected SCFM2-Scnn1b-Tg mice mainly develop obstructive lung disease that is mixed with restrictive disorder, making this model ideal to test the effectiveness of therapies designed to improve lung function in pwCF. This evidence concerns the gene SCNN1B and Airway obstruction.